Study on the Safety and Effectiveness of EIK1001 and Pembrolizumab for Patients with Advanced Melanoma
- Substances:PembrolizumabResiquimod Sulfate
Italy- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Pembrolizumab
Rare diseases
Investigational molecules
Locations
ItalyStudy on Zanidatamab and Chemotherapy for Patients with Metastatic HER2-Positive Breast Cancer After Trastuzumab Deruxtecan Treatment
ItalyStudy on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response
ItalyStudy on Ponatinib for Treating Recurrent or Refractory Leukemias and Solid Tumors in Children
ItalyStudy on the Long-term Safety of Efgartigimod for Children with Generalized Myasthenia Gravis
ItalyStudy on the Use of Methylprednisolone Sodium Succinate for Treating Patients with Acute Myocarditis and Mildly Reduced Heart Function
ItalyStudy on Long-Term Safety of Luspatercept for Patients with Myelodysplastic Syndrome, Beta-Thalassemia, or Myelofibrosis Who Previously Participated in Luspatercept Trials
ItalyStudy on Preventing Cardiovascular Collapse in Critically Ill Adults Using Noradrenaline Tartrate During Tracheal Intubation
ItalyStudy of apremilast compared to placebo in children aged 5-17 years with juvenile psoriatic arthritis
ItalyLong-term Safety Study of Delandistrogene Moxeparvovec for Patients with Duchenne Muscular Dystrophy Who Previously Received SRP-9001
ItalyStudy of Axitinib and Nivolumab for Patients with Metastatic Renal Cell Carcinoma Not Responding Completely to Initial Treatment
ItalyStudy of AZD5305 with Abiraterone Acetate and Darolutamide in Men with Metastatic Castration-Sensitive Prostate Cancer
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.